|
|
| Line 26: |
Line 26: |
| <span style="display:none">availableVariable::year</span> | | <span style="display:none">availableVariable::year</span> |
| <span style="display:none">dataLevel::national level</span> | | <span style="display:none">dataLevel::national level</span> |
| | <span style="display:none">isReport</span> |
| <span style="display:none">hasCancerType::C50: Breast cancer</span> | | <span style="display:none">hasCancerType::C50: Breast cancer</span> |
| <span style="display:none">isReport</span>
| |
| <span style="display:none">hasCancerType::C00-D48: All neoplasms</span> | | <span style="display:none">hasCancerType::C00-D48: All neoplasms</span> |
| <span style="display:none">hasCancerType::C00-C97: All cancer types</span> | | <span style="display:none">hasCancerType::C00-C97: All cancer types</span> |
| <span style="display:none">hasCancerType::C00-C14: Mouth/throat cancers</span>
| |
| <span style="display:none">hasCancerType::C15-C26: Digestive system cancers</span>
| |
| <span style="display:none">hasCancerType::C30-C39: Lung/chest cancers</span>
| |
| <span style="display:none">hasCancerType::C40-C41: Bone cancers</span>
| |
| <span style="display:none">hasCancerType::C43-C44: Skin cancers/melanoma</span>
| |
| <span style="display:none">hasCancerType::C45-C49: Soft tissue cancer</span>
| |
| <span style="display:none">hasCancerType::C51-C58: Female genitalia cancers</span>
| |
| <span style="display:none">hasCancerType::C60-C63: Male genitalia cancer</span>
| |
| <span style="display:none">hasCancerType::C64-C68: Urinary system cancers</span>
| |
| <span style="display:none">hasCancerType::C69-C72: Eye and brain cancer</span>
| |
| <span style="display:none">hasCancerType::C73-C75: Thyroid and other gland cancers</span>
| |
| <span style="display:none">hasCancerType::C76-C80: Cancers of unknown or unspecified areas</span>
| |
| <span style="display:none">hasCancerType::C81-C96: Cancers of the blood and immune system</span>
| |
| <span style="display:none">hasCancerType::C97-C97: Cancers in multiple locations from the start</span>
| |
| <span style="display:none">hasCancerType::D00-D09: Early-stage cancers not yet spread</span>
| |
| <span style="display:none">hasCancerType::D10-D36: Benign tumour</span>
| |
| <span style="display:none">hasCancerType::D37-D48: Growths of uncertain nature</span>
| |
| <span style="display:none">hasCancerType::unknown</span>
| |
Revision as of 19:15, 10 December 2025
forpolicymakers
thenetherlandscountry
Go back to The Netherlands page
Primary purpose: To detect breast cancer early, leading to better prognosis, and it is coordinated by the RIVM, with annual monitoring by IKNL to ensure program quality and identify trends and bottlenecks.
Sponsor, manager or home institution: Integraal Kankercentrum Nederland.
Type of information: screening, cancer incidence, number of deaths, year. The number screened in the reporting year; Invitations, participation rate and referrals; Incidence and mortality rates. Click here to learn more.
Data level: national level.
Cancer areas of interest: C50: Breast cancer. Click here to learn more.
Access to information: Click here to access.
Lobular
Breast
Nipple
Areola
Ductal
dataOwner::Integraal Kankercentrum Nederland
availableVariable::screening
availableVariable::cancer incidence
availableVariable::number of deaths
availableVariable::year
dataLevel::national level
isReport
hasCancerType::C50: Breast cancer
hasCancerType::C00-D48: All neoplasms
hasCancerType::C00-C97: All cancer types
